Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Not Yet Recruiting

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

NCT06827639

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +38 more
Locations: Hopital Timone enfants - plateforme d'Immunoprofiling Marseille, France

View Trial Details

Not Yet Recruiting

Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer

NCT06817759

Conditions: Anxiety Disorders, Blood Cancer, Blood Protein Disorders, +24 more
Locations: Centre de Recherche de l'Hôpital Maissonneuve-Rosemont Montreal, Quebec, Canada

View Trial Details

Not Yet Recruiting

MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma

NCT06557330

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma

NCT06737835

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Nuclear medicine- Assiut University Hospital Asyut, Egypt

View Trial Details

Not Yet Recruiting

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

NCT06647329

Conditions: CAR-T Cell Therapy, Disease Attributes, Hemic and Lymphatic Diseases, +11 more
Locations: the First Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)

NCT06549335

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China

View Trial Details

Not Yet Recruiting

A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL

NCT06573645

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL

NCT06573151

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Real-World Study on Extranodal Lymphoma

NCT06573099

Conditions: Diffuse Large B Cell Lymphoma, Extranodal Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

RAT-HEMATO : Return to Work After Malignant Hemopathy

NCT06262789

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Angers University hospital Angers, France

Brest University Hospital, Morvan Site Brest, France

Caen University hospital Caen, France

Rennes University Hospital, Pontchaillou site Rennes, France

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions